Per-Se Technologies to Acquire NDCHealth Corporation; Wolters Kluwer to Purchase NDCHealth's Information Management Business
29 Agosto 2005 - 12:09AM
PR Newswire (US)
- Transaction valued at approximately $1 billion ALPHARETTA, Ga.
and ATLANTA, Aug. 29 /PRNewswire-FirstCall/ -- Per-Se Technologies,
Inc. (NASDAQ:PSTI) and NDCHealth Corporation (NYSE:NDC) today
announced that definitive agreements have been signed for the sale
of NDCHealth, a leading provider of healthcare technology and
information solutions, in a transaction valued at approximately $1
billion. Per-Se Technologies will acquire Atlanta-based NDCHealth,
including the physician, hospital and retail pharmacy businesses,
for total consideration of approximately $665 million, which
includes refinancing NDCHealth's outstanding debt at closing,
currently totaling approximately $270 million. As part of the
transaction, Wolters Kluwer (ASE:WKL), based in Amsterdam, the
Netherlands, will purchase the pharmaceutical information
management business from NDCHealth for $382 million in cash. The
combined transaction, after income taxes, debt refinancing and
transaction costs, will result in compensation to NDCHealth's
shareholders of $19.50 per share, with at least $13.00 paid in cash
and up to $6.50 paid in Per-Se stock, as to be determined by Per-Se
and to be announced prior to the shareholder meetings. Neil
Williams, lead independent director of NDCHealth, stated, "After an
extensive and thorough sale process initiated in March, the
NDCHealth Board of Directors believes these combined transactions
represent the best value for NDCHealth's shareholders and offer the
best strategic fit for the Company's customers and employees."
"Per-Se's and Wolters Kluwer's resources and strategic focus on key
segments of the healthcare marketplace should create substantial
benefits for our pharmacy, hospital, physician and pharmaceutical
customers," commented Walter M. Hoff, NDCHealth's chairman and
chief executive officer. "The addition of NDCHealth's businesses
and expertise will also enable both Per-Se and Wolters Kluwer to
offer a wider range of products to an expanded base of customers."
Acquisition Expands Per-Se's Leadership Position in Healthcare
Services and Technology Market Per-Se's purchase of NDCHealth
combines Per-Se's leading position in business process outsourcing
for hospital-affiliated physicians with NDCHealth's leading
positions in hospital, physician and retail pharmacy technology and
solutions. The acquisition will increase Per-Se's revenue by more
than 60% on a trailing 12-month pro forma basis as of June 30,
2005. The complementary revenue cycle management offerings of the
two companies will provide future opportunities to improve the
business of healthcare. "Per-Se and NDCHealth share the strategic
focus of improving the financial success of provider
organizations," stated Philip M. Pead, Per-Se's chairman, president
and chief executive officer. "By combining our complementary
solutions and services, we will be able to improve the flow of
information at the point of care enabling providers, patients and
payers to take advantage of a more efficient healthcare system."
NDCHealth provides software and network solutions that help
hospitals, retail pharmacies and small-office physicians improve
the financial and clinical efficiencies of their respective
businesses. NDCHealth's Intelligent Network, which processes more
than 5 billion transactions annually, is an integral part of its
revenue cycle management connectivity. NDCHealth services
approximately 1,800 hospitals and healthcare organizations,
approximately 100,000 office-based physicians, and approximately
50,000 retail pharmacies. Per-Se is the leading provider of
business process outsourcing services to hospital-affiliated
physicians. In addition, Per-Se's revenue cycle and resource
management solutions enable hospitals to improve their revenues and
reduce their operating costs. Per-Se services more than 19,000
physicians and 2,000 hospitals. Acquisition Expected to be Earnings
and Cash Flow Accretive in Year One The combined entity would have
pro forma revenues of approximately $590 million as of June 30,
2005, and improved operating profitability compared to their
separate historical performances. The combination of the two
companies is expected to generate accretion from operational and
other synergies of between $15 million and $20 million in year one.
Per-Se expects that the acquisition, excluding transaction-related
and other one-time costs, will be accretive to earnings per share
and significantly accretive to cash flow per share in year one.
"Both Per-Se and NDCHealth generate significant levels of operating
cash flow due to the recurring revenue nature of both businesses,"
stated Pead. Financing of Transaction Per-Se intends to raise
approximately $410 million in new debt related to the transaction
to refinance NDCHealth's outstanding debt and fund cash to
shareholders. NDCHealth's outstanding debt, currently totaling
approximately $270 million, consists of its $200 million 10 1/2%
senior subordinated notes due December 1, 2012, and its senior
secured credit facility that includes a six-year term loan and a
revolving credit facility. Per-Se has received a financing
commitment from Bank of America, N.A. for the transaction. "Through
our acquisition of NDCHealth, we are focused on capitalizing on
opportunities that will improve the efficiencies of our customers'
businesses and of our healthcare system," stated Pead. "The
combination of Per-Se's and NDCHealth's solutions and people
provides synergy and growth prospects to maximize future value for
our shareholders." Closing Conditions, Shareholder Approval and
Anticipated Closing The transaction is subject to approval by the
shareholders of both Per-Se and NDCHealth. The parties expect to
complete the transaction within three to six months. Each
transaction is subject to regulatory review under U.S. antitrust
laws and other customary closing conditions. The completion of Per-
Se's transaction is also subject to the closing of the Wolters
Kluwer transaction. The Blackstone Group L.P. and Goldman, Sachs
& Co. acted as financial advisors to NDCHealth in the sale
process, and provided fairness opinions on the sale of NDCHealth.
Banc of America Securities provided a fairness opinion to Per-Se on
the transaction. Per-Se Technologies Investor Conference Call
Per-Se will host a conference call for institutional investors and
security analysts to discuss the acquisition on August 29, 2005, at
10:30 a.m. Eastern time. Interested participants may join the call
by dialing 888/ 566- 5790 (US) or 210/ 839-8502 (International),
using passcode PSTI. The conference call may be accessed via
Per-Se's website at http://www.per-se.com/ in the Investors section
by selecting the Webcast link. A telephone replay of the call will
be available for 14 days following completion of the call at 866/
369-3653 (US) or 203/ 369-0245 (International), using passcode
1234. The call will be archived on Per-Se's website for
approximately 60 days. Per-Se Technologies Media Question and
Answer Session A question and answer session will be held with the
media at 11:30 am Eastern time on August 29, 2005, following the
investor conference call. Interested media may join the question
and answer session by dialing 888/ 790-1714 (US) or 210/ 234-0037
(International), using passcode 5232. The session may be accessed
via Per-Se's website at http://www.per-se.com/ in the Investors
section by selecting the Webcast link. A telephone replay of the
session will be available for 14 days following completion of the
call at 888/ 566-0608 (US) or 203/ 369-3618 (International), using
passcode 1234. The call will be archived on Per-Se's website for
approximately 60 days. About NDCHealth NDCHealth is a leading
information solutions company serving all sectors of healthcare.
Its network solutions automate the exchange of information among
pharmacies, payers, hospitals and physicians. Its systems and
information management solutions help improve operational
efficiencies and business decision making for providers, retail
pharmacy and pharmaceutical manufacturers. Headquartered at
Atlanta, Ga., NDCHealth provides information vital to the delivery
of healthcare every day. For more information, visit
http://www.ndchealth.com/ About Per-Se Technologies Per-Se
Technologies (NASDAQ:PSTI) is the leader in Connective Healthcare.
Connective Healthcare solutions from Per-Se enable physicians and
hospitals to achieve their income potential by creating an
environment that streamlines and simplifies the complex
administrative burden of providing healthcare. Per-Se's Connective
Healthcare solutions help reduce administrative expenses, increase
revenue and accelerate the movement of funds to benefit providers,
payers and patients. More information about Alpharetta, Georgia-
based Per-Se is available at http://www.per-se.com/. For more
information about Wolters Kluwer, including their press release
announcing this transaction, please visit their website at
http://www.wolterskluwer.com/. Safe Harbor Statement This Press
Release contains statements that constitute forward-looking
statements within the meaning of the Securities Act of 1933 and the
Securities Exchange Act of 1934, as amended by the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements contained in this Press Release include the intent,
belief or current expectations of NDCHealth Corporation and Per-Se
Technologies and members of their respective management teams with
respect to the companies' future business operations as well as the
assumptions upon which such statements are based. Forward-looking
statements include specifically, but are not limited to, proforma
revenue projections, cost synergy projections, earnings per share
accretion predictions, and cash flow predictions for Per-Se; total
debt to be raised by Per-Se; and the timing of the closing of the
transaction. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future
performance, and involve risks and uncertainties, and that actual
results may differ materially from those contemplated by such
forward-looking statements. Important factors that could cause
actual results to differ materially from those contemplated by the
forward-looking statements in this Press Release include, but are
not limited to, failure to realize improvements in performance,
efficiency and profitability, failure to complete anticipated sales
under negotiations, failure to implement successfully sales
backlog, lack of revenue growth, client losses, failure to realize
cost synergies, failure to raise the necessary debt financing to
fund the transaction and adverse developments with respect to the
operation or performance of the respective company's business
units, adverse developments with respect to the market price of
Per-Se Technologies' common stock, failure by either company to
obtain the required shareholder or regulatory approvals, or other
failures to close the transaction. Additional factors that could
cause actual results to differ materially from those contemplated
within this Press Release can also be found in the reports filed
with the Securities and Exchange Commission (the "SEC") by Per-Se
Technologies and NDCHealth Corporation, which are available at
http://www.sec.gov/. NDCHealth Corporation and Per-Se Technologies
disclaim any responsibility to update any forward-looking
statements. Important Legal Information This communication is being
made in respect of the proposed acquisition transaction involving
Per-Se Technologies and NDCHealth Corporation. This press release
shall not constitute an offer of any securities for sale. In
connection with the proposed transaction, NDCHealth Corporation and
Per-Se Technologies will prepare a registration statement on Form
S-4 containing a joint proxy statement/prospectus for the
shareholders of both companies to be filed with the SEC, and each
will be filing other documents regarding the proposed transaction
with the SEC as well. Before making any voting or investment
decision, investors are urged to read the joint proxy
statement/prospectus regarding the proposed transaction and any
other relevant documents carefully in their entirety when they
become available, as well as any amendments and supplements
thereto, as they will contain important information about the
proposed transaction. The final joint proxy statement/prospectus
will be mailed to the shareholders of both NDCHealth and Per-Se.
You may obtain copies of all documents filed with the SEC regarding
this transaction, free of charge, at the SEC's website
(http://www.sec.gov/). You may also obtain these documents, free of
charge, from NDCHealth's website (http://www.ndchealth.com/) under
the tab "investor Relations" through the "SEC Filing" link. You may
also obtain these documents, free of charge, from Per- Se's website
(http://www.per-se.com/) under the tab "Investors" through the "SEC
Filing" link. Participants in This Transaction NDCHealth
Corporation and Per-Se Technologies and their respective directors
and executive officers may be deemed participants in the
solicitation of proxies from stockholders in connection with this
transaction. Information about the directors and executive officers
of NDCHealth and Per-Se Technologies and information about other
persons who may be deemed participants in this transaction will be
included in the joint proxy statement/prospectus. You can find
information about NDCHealth's executive officers and directors in
NDCHealth's definitive proxy statement filed with the SEC on
September 15, 2004. You can find information about Per-Se
Technologies' executive officers and directors in Per-Se's
definitive proxy statement filed with the SEC on March 25, 2005.
Editor's note: Per-Se Technologies is a registered trademark of
Per-Se Technologies, Inc. All other trademarks are the property of
their respective owners. DATASOURCE: NDCHealth Corporation CONTACT:
Robert Borchert of NDCHealth, +1-404-728-2906, ; or Michele Howard
Per-Se Technologies, Inc., +1-770-237-7827, Web site:
http://www.ndchealth.com/ http://www.per-se.com/
http://www.wolterskluwer.com/
Copyright
Ndchealth (NYSE:NDC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Ndchealth (NYSE:NDC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024